Table 1. The study patient details.
Patient ID |
Samples | Age (YEARS) |
Sex | Clinical phenotype | |
---|---|---|---|---|---|
1 | AF 19 | IC-BM And VB-BM |
13 | Female | Adolescent Idiopathic Scoliosis |
2 | AF 20 | IC-BM And VB-BM |
15 | Female | Adolescent Idiopathic Scoliosis |
3 | AF 23 | IC-BM And VB-BM |
13 | Female | Adolescent Idiopathic Scoliosis |
4 | AF 24 | IC-BM And VB-BM |
14 | Female | Adolescent Idiopathic Scoliosis |
5 | AF 26 | IC-BM And VB-BM |
14 | Male | Adolescent Idiopathic Scoliosis |
6 | AF 27 | IC-BM And VB-BM |
16 | Male | Adolescent Idiopathic Scoliosis |
7 | AF 28 | IC-BM And VB-BM |
14 | Male | Adolescent Idiopathic Scoliosis |
8 | AF 29 | IC-BM And VB-BM |
15 | Male | Adolescent Idiopathic Scoliosis |
9 | AF 31 | IC-BM And VB-BM |
15 | Female | Adolescent Idiopathic Scoliosis |
10 | AF 32 | IC-BM And VB-BM |
16 | Male | Adolescent Idiopathic Scoliosis |
11 | AF 33 | IC-BM And VB-BM |
16 | Female | Adolescent Idiopathic Scoliosis |
12 | AF 34 | IC-BM And VB-BM |
14 | Female | Adolescent Idiopathic Scoliosis |
13 | AF 35 | IC-BM And VB-BM |
15 | Female | Adolescent Idiopathic Scoliosis |
14 | AF 39 | IC-BM And VB-BM |
15 | Female | Adolescent Idiopathic Scoliosis |
15 | AF 40 | IC-BM And VB-BM |
16 | Female | Adolescent Idiopathic Scoliosis |
16 | AF 43 | IC-BM And VB-BM |
16 | female | Adolescent Idiopathic Scoliosis |
17 | AF 48 | IC-BM And VB-BM |
13 | female | Adolescent Idiopathic Scoliosis |
18 | AF 49 | IC-BM And VB-BM |
15 | female | Adolescent Idiopathic Scoliosis |
19 | AF 50 | IC-BM And VB-BM |
17 | male | Adolescent Idiopathic Scoliosis |
20 | AF 51 | IC-BM And VB-BM |
75 | male | Decompression/fusion |
21 | AF 53 | IC-BM And VB-BM |
65 | male | Decompression/fusion |
22 | AF 55 | IC-BM And VB-BM |
79 | female | Decompression/fusion |
23 | AF 57 | IC-BM And VB-BM |
39 | female | Decompression/fusion |
24 | AF 58 | IC-BM And VB-BM |
46 | Female | Decompression/fusion |
25 | AF 62 | IC-BM And VB-BM |
67 | Female | Decompression/fusion |
The list of the age, gender, sample and clinical phenotype for the patients included in the study.